RIGL insider trading
Open-market stock trades by Rigel Pharmaceuticals (RIGL) executives and directors: who bought or sold, how many shares, at what price and when.
RIGL insider trades
| Date | Insider | Role | Trade | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Jun 22, 2026 | Ali-Jackson Kamil | director | Sell | 2,500 | $35.00 | $87.50K |
| May 26, 2026 | Ali-Jackson Kamil | director | Sell | 2,500 | $29.17 | $72.92K |
| Feb 20, 2026 | MOOS WALTER H | director | Sell | 4,000 | $36.36 | $145.44K |
| Feb 4, 2025 | Schorno Dean L | EVP & Chief Financial Officer | Sell | 2,036 | $20.92 | $42.60K |
| Feb 5, 2025 | Schorno Dean L | EVP & Chief Financial Officer | Sell | 1,734 | $21.93 | $38.02K |
| Feb 4, 2025 | Santos David A | EVP, Chief Commercial Officer | Sell | 2,125 | $20.92 | $44.46K |
| Feb 5, 2025 | Santos David A | EVP, Chief Commercial Officer | Sell | 1,796 | $21.93 | $39.38K |
- RIGL insiders bought $0.00 and sold $470.32K in open-market trades over their last 7 filings.
Updated 2026-11-05 12:48 UTC